Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T22:52:05.485Z.
Calculation as of: 2026-10-06T22:52:05.485Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 16c1118283d3d380e79e54cd720e88a66b4293c4936e446a72c17353f5d031e1
PEG RATIO
N/A
NeuroOne Medical Technologies Corporation
Market Cap
$9.83M
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| NeuroOne Medical Technologies Corporation (NMTC) | $9.83M | N/A |
| Valion Bio, Inc. (VBIO)vs › | $9.86M | N/A |
| MetaVia Inc. (MTVA)vs › | $9.75M | N/A |
| Satellos Bioscience Inc. (MSLE)vs › | $9.71M | N/A |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.06M | N/A |
| Senti Biosciences, Inc. (SNTI)vs › | $10.06M | N/A |
| Tvardi Therapeutics, Inc. (TVRD)vs › | $10.13M | N/A |
| Ainos, Inc. (AIMD)vs › | $9.50M | N/A |
| Lifeward Ltd. (LFWD)vs › | $10.21M | N/A |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $10.45M | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
